Register entry
Kyowa Pharma Chemical Co., Ltd.
- Registered sites
- 1
- Drug products
- 6
- Live patents
- 0
- Countries
- 1
- Base
- Japan
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingPackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Kyowa Pharma Chemical Co., Ltd. | TakaokaJapan | Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging | 3003128853 |
Catalogue
Marketed products
6Showing 6 of 6.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Bimatoprost | POWDER | BULK INGREDIENT |
| - | Dinoprostone | POWDER | BULK INGREDIENT |
| - | Istradefylline | POWDER | BULK INGREDIENT |
| - | Latanoprost | LIQUID | BULK INGREDIENT |
| - | Olopatadine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Tranexamic Acid | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.